Cargando…

Neuroprotective Effect of Barbaloin on Streptozotocin-Induced Cognitive Dysfunction in Rats via Inhibiting Cholinergic and Neuroinflammatory Cytokines Pathway—TNF-α/IL-1β/IL-6/NF-κB

[Image: see text] Streptozotocin (STZ) impairs memory in rats through altering the central nervous systems (CNS) as a result of impaired cholinergic dysfunction, oxidative stress, persistent hyperglycemia, and alterations in the glucagon-like peptide (GLP). In this model cholinergic agonist, antioxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Omer, Asma B., Afzal, Obaid, Altamimi, Abdulmalik S. A., Patil, Shaktipal, AlGhamdi, Shareefa A., Alghamdi, Amira M., Alzarea, Sami I., Almalki, Waleed Hassan, Kazmi, Imran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979232/
https://www.ncbi.nlm.nih.gov/pubmed/36872976
http://dx.doi.org/10.1021/acsomega.2c08277
_version_ 1784899685454970880
author Omer, Asma B.
Afzal, Obaid
Altamimi, Abdulmalik S. A.
Patil, Shaktipal
AlGhamdi, Shareefa A.
Alghamdi, Amira M.
Alzarea, Sami I.
Almalki, Waleed Hassan
Kazmi, Imran
author_facet Omer, Asma B.
Afzal, Obaid
Altamimi, Abdulmalik S. A.
Patil, Shaktipal
AlGhamdi, Shareefa A.
Alghamdi, Amira M.
Alzarea, Sami I.
Almalki, Waleed Hassan
Kazmi, Imran
author_sort Omer, Asma B.
collection PubMed
description [Image: see text] Streptozotocin (STZ) impairs memory in rats through altering the central nervous systems (CNS) as a result of impaired cholinergic dysfunction, oxidative stress, persistent hyperglycemia, and alterations in the glucagon-like peptide (GLP). In this model cholinergic agonist, antioxidant and antihyperglycemic treatment has been shown to have positive effects. Barbaloin has a variety of pharmacological effects. However, there is no evidence on how barbaloin improves memory dysfunction caused by STZ. Thus, we examined its effectiveness against cognitive damage caused by STZ at a dose of 60 mg/kg i.p. in Wistar rats. Blood glucose levels (BGL) and body weight (BW) were assessed. To assess learning and memory skills, the Y-maze test and Morris water maze (MWM) test were utilized. Superoxide dismutase (SOD), malondialdehyde (MDA), catalase (CAT), and glutathione (GSH) as oxidative stress markers were regulated to reverse the cognitive deterioration, and choline-acetyltransferase (ChAT) and acetyl-cholinesterase (AChE) as indicators of cholinergic dysfunction, nuclear factor kappa-B (NF-κB), IL-1β (interleukin-1β), IL-6, and tumor necrosis factor-α (TNF-α) contents were used. Barbaloin treatment thereby significantly decreased the BW and learning and memory capacities, resulting in substantial behavioral improvement in the Y-maze and MWM test. BGL, SOD, CAT, MDA, GSH, AChE, ChAT, NF-κB, IL-6, TNF-α, and IL-1β levels were also altered. In conclusion, the findings revealed that barbaloin had a protective impact against cognitive dysfunction caused by STZ.
format Online
Article
Text
id pubmed-9979232
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-99792322023-03-03 Neuroprotective Effect of Barbaloin on Streptozotocin-Induced Cognitive Dysfunction in Rats via Inhibiting Cholinergic and Neuroinflammatory Cytokines Pathway—TNF-α/IL-1β/IL-6/NF-κB Omer, Asma B. Afzal, Obaid Altamimi, Abdulmalik S. A. Patil, Shaktipal AlGhamdi, Shareefa A. Alghamdi, Amira M. Alzarea, Sami I. Almalki, Waleed Hassan Kazmi, Imran ACS Omega [Image: see text] Streptozotocin (STZ) impairs memory in rats through altering the central nervous systems (CNS) as a result of impaired cholinergic dysfunction, oxidative stress, persistent hyperglycemia, and alterations in the glucagon-like peptide (GLP). In this model cholinergic agonist, antioxidant and antihyperglycemic treatment has been shown to have positive effects. Barbaloin has a variety of pharmacological effects. However, there is no evidence on how barbaloin improves memory dysfunction caused by STZ. Thus, we examined its effectiveness against cognitive damage caused by STZ at a dose of 60 mg/kg i.p. in Wistar rats. Blood glucose levels (BGL) and body weight (BW) were assessed. To assess learning and memory skills, the Y-maze test and Morris water maze (MWM) test were utilized. Superoxide dismutase (SOD), malondialdehyde (MDA), catalase (CAT), and glutathione (GSH) as oxidative stress markers were regulated to reverse the cognitive deterioration, and choline-acetyltransferase (ChAT) and acetyl-cholinesterase (AChE) as indicators of cholinergic dysfunction, nuclear factor kappa-B (NF-κB), IL-1β (interleukin-1β), IL-6, and tumor necrosis factor-α (TNF-α) contents were used. Barbaloin treatment thereby significantly decreased the BW and learning and memory capacities, resulting in substantial behavioral improvement in the Y-maze and MWM test. BGL, SOD, CAT, MDA, GSH, AChE, ChAT, NF-κB, IL-6, TNF-α, and IL-1β levels were also altered. In conclusion, the findings revealed that barbaloin had a protective impact against cognitive dysfunction caused by STZ. American Chemical Society 2023-02-16 /pmc/articles/PMC9979232/ /pubmed/36872976 http://dx.doi.org/10.1021/acsomega.2c08277 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Omer, Asma B.
Afzal, Obaid
Altamimi, Abdulmalik S. A.
Patil, Shaktipal
AlGhamdi, Shareefa A.
Alghamdi, Amira M.
Alzarea, Sami I.
Almalki, Waleed Hassan
Kazmi, Imran
Neuroprotective Effect of Barbaloin on Streptozotocin-Induced Cognitive Dysfunction in Rats via Inhibiting Cholinergic and Neuroinflammatory Cytokines Pathway—TNF-α/IL-1β/IL-6/NF-κB
title Neuroprotective Effect of Barbaloin on Streptozotocin-Induced Cognitive Dysfunction in Rats via Inhibiting Cholinergic and Neuroinflammatory Cytokines Pathway—TNF-α/IL-1β/IL-6/NF-κB
title_full Neuroprotective Effect of Barbaloin on Streptozotocin-Induced Cognitive Dysfunction in Rats via Inhibiting Cholinergic and Neuroinflammatory Cytokines Pathway—TNF-α/IL-1β/IL-6/NF-κB
title_fullStr Neuroprotective Effect of Barbaloin on Streptozotocin-Induced Cognitive Dysfunction in Rats via Inhibiting Cholinergic and Neuroinflammatory Cytokines Pathway—TNF-α/IL-1β/IL-6/NF-κB
title_full_unstemmed Neuroprotective Effect of Barbaloin on Streptozotocin-Induced Cognitive Dysfunction in Rats via Inhibiting Cholinergic and Neuroinflammatory Cytokines Pathway—TNF-α/IL-1β/IL-6/NF-κB
title_short Neuroprotective Effect of Barbaloin on Streptozotocin-Induced Cognitive Dysfunction in Rats via Inhibiting Cholinergic and Neuroinflammatory Cytokines Pathway—TNF-α/IL-1β/IL-6/NF-κB
title_sort neuroprotective effect of barbaloin on streptozotocin-induced cognitive dysfunction in rats via inhibiting cholinergic and neuroinflammatory cytokines pathway—tnf-α/il-1β/il-6/nf-κb
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979232/
https://www.ncbi.nlm.nih.gov/pubmed/36872976
http://dx.doi.org/10.1021/acsomega.2c08277
work_keys_str_mv AT omerasmab neuroprotectiveeffectofbarbaloinonstreptozotocininducedcognitivedysfunctioninratsviainhibitingcholinergicandneuroinflammatorycytokinespathwaytnfail1bil6nfkb
AT afzalobaid neuroprotectiveeffectofbarbaloinonstreptozotocininducedcognitivedysfunctioninratsviainhibitingcholinergicandneuroinflammatorycytokinespathwaytnfail1bil6nfkb
AT altamimiabdulmaliksa neuroprotectiveeffectofbarbaloinonstreptozotocininducedcognitivedysfunctioninratsviainhibitingcholinergicandneuroinflammatorycytokinespathwaytnfail1bil6nfkb
AT patilshaktipal neuroprotectiveeffectofbarbaloinonstreptozotocininducedcognitivedysfunctioninratsviainhibitingcholinergicandneuroinflammatorycytokinespathwaytnfail1bil6nfkb
AT alghamdishareefaa neuroprotectiveeffectofbarbaloinonstreptozotocininducedcognitivedysfunctioninratsviainhibitingcholinergicandneuroinflammatorycytokinespathwaytnfail1bil6nfkb
AT alghamdiamiram neuroprotectiveeffectofbarbaloinonstreptozotocininducedcognitivedysfunctioninratsviainhibitingcholinergicandneuroinflammatorycytokinespathwaytnfail1bil6nfkb
AT alzareasamii neuroprotectiveeffectofbarbaloinonstreptozotocininducedcognitivedysfunctioninratsviainhibitingcholinergicandneuroinflammatorycytokinespathwaytnfail1bil6nfkb
AT almalkiwaleedhassan neuroprotectiveeffectofbarbaloinonstreptozotocininducedcognitivedysfunctioninratsviainhibitingcholinergicandneuroinflammatorycytokinespathwaytnfail1bil6nfkb
AT kazmiimran neuroprotectiveeffectofbarbaloinonstreptozotocininducedcognitivedysfunctioninratsviainhibitingcholinergicandneuroinflammatorycytokinespathwaytnfail1bil6nfkb